| Q42439006 | 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. |
| Q40313659 | An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen |
| Q37048752 | An update on apocrine lesions of the breast |
| Q38448708 | Androgen and vitamin D receptor expression in archival human breast tumors |
| Q33338236 | Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors |
| Q35585902 | Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors |
| Q53438825 | Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. |
| Q43246075 | Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation |
| Q38451314 | Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. |
| Q42504088 | Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma |
| Q28079858 | Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers |
| Q44596879 | Apocrine change in fine-needle aspiration biopsy: nuclear morphometry and DNA image cytometry. |
| Q46827099 | Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype. |
| Q34442958 | Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses |
| Q41251750 | Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia |
| Q47256004 | Clinicopathological study of a dimorphic variant of breast carcinoma. |
| Q83147969 | EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast |
| Q35872734 | Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis |
| Q37229990 | Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer |
| Q46620153 | Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast |
| Q53596418 | Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions. |
| Q43249156 | Expression of androgen receptors in primary breast cancer |
| Q46570978 | Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast |
| Q43706967 | Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women |
| Q34497523 | FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. |
| Q53405502 | Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes. |
| Q34306784 | HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast |
| Q44115152 | Histological and immunohistochemical analysis of apocrine breast carcinoma |
| Q54656221 | Hormone receptor profile of apocrine lesions of the breast. |
| Q37242122 | Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors |
| Q46630833 | Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma |
| Q36673759 | Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27 |
| Q46773052 | Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients |
| Q36251444 | Management of unusual histological types of breast cancer |
| Q38537958 | Molecular and diagnostic features of apocrine breast lesions. |
| Q41130064 | Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort |
| Q36172494 | Non-operative breast pathology: apocrine lesions |
| Q46169949 | Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast |
| Q39499250 | Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis |
| Q45045568 | Salivary duct carcinoma with neuroendocrine features: report of a case with cytological and immunohistochemical study |
| Q37575140 | Squamous cell carcinoma with apocrine features of the breast: A case report |
| Q36434480 | The enigmatic nature of apocrine breast lesions |
| Q47631123 | The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer. |
| Q35573116 | Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies |